Synmosa Biopharma Corporation

Synmosa Biopharma Corporationverified

4114.TWO

Price:

$31.5

Market Cap:

$15.94B

Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, hormones, and other forms. It also offers contract manufacturing services. In addition, it exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nica...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2007-12-31

Stock Exchange

TWO

Ticker

4114.TWO

The ROE as of December 2025 (TTM) for Synmosa Biopharma Corporation (4114.TWO) is 9.49%

According to Synmosa Biopharma Corporation’s latest financial reports and current stock price. The company's current ROE is 9.49%. This represents a change of 302.68% compared to the average of 2.36% of the last 4 quarters.

Synmosa Biopharma Corporation (4114.TWO) Historical ROE (quarterly & annually)

How has 4114.TWO ROE performed in the past?

The mean historical ROE of Synmosa Biopharma Corporation over the last ten years is 9.23%. The current 9.49% ROE has changed 2.78% with respect to the historical average. Over the past ten years (40 quarters), 4114.TWO's ROE was at its highest in in the June 2024 quarter at 2.93%. The ROE was at its lowest in in the December 2022 quarter at 0%.

Quarterly (TTM)
Annual

Average

9.23%

Median

9.18%

Minimum

1.35%

Maximum

15.04%

Synmosa Biopharma Corporation (4114.TWO) ROE by Quarter and Year

Discovering the peaks and valleys of Synmosa Biopharma Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 949.02%

Maximum Annual ROE = 15.04%

Minimum Annual Increase = -54.46%

Minimum Annual ROE = 1.35%

Quarterly (TTM)
Annual
YearROEChange
20249.50%7.11%
20238.87%-41.07%
202215.04%132.96%
20216.46%-54.46%
202014.18%949.02%

Synmosa Biopharma Corporation (4114.TWO) Average ROE

How has 4114.TWO ROE performed in the past?

The current ROE of Synmosa Biopharma Corporation (4114.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

11.14%

5-year avg

10.81%

10-year avg

9.23%

Synmosa Biopharma Corporation (4114.TWO) ROE vs. Peers

How is 4114.TWO’s ROE compared to its peers?

Synmosa Biopharma Corporation’s ROE is less than Grape King Bio Ltd (12.30%), less than Handa Pharmaceuticals, Inc. (17.53%), less than YungShin Global Holding Corporation (12.49%), less than TTY Biopharm Company Limited (25.06%), less than Great Tree Pharmacy Co., Ltd. (17.76%), greater than Alar Pharmaceuticals Inc. (-1.19%), less than ScinoPharm Taiwan, Ltd. (1.82%), less than Excelsior Medical Co., Ltd. (9.22%), greater than Foresee Pharmaceuticals Co., Ltd. (-98.79%), less than Standard Chem & Pharm Co. Ltd. (15.44%),

Build a custom stock screener for Synmosa Biopharma Corporation (4114.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synmosa Biopharma Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Synmosa Biopharma Corporation (4114.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Synmosa Biopharma Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Synmosa Biopharma Corporation's ROE?

How is the ROE calculated for Synmosa Biopharma Corporation (4114.TWO)?

What is the highest ROE for Synmosa Biopharma Corporation (4114.TWO)?

What is the 3-year average ROE for Synmosa Biopharma Corporation (4114.TWO)?

What is the 5-year average ROE for Synmosa Biopharma Corporation (4114.TWO)?

How does the current ROE for Synmosa Biopharma Corporation (4114.TWO) compare to its historical average?